Pipeline Noticeocds-b5fd17-044c0f20-073f-4bf9-859a-c295acdd7e63
NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
CM/PHR/22/5693 NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
Buyer
NHS England
Value
£74,000,000
Published
5 Dec 2022
Closes
5 Dec 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
£74,000,000
CM/PHR/22/5693 NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
11 Nov 2022
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Future opportunity notice on Contracts Finder
11 Nov 2022
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.